This research group has different in vitro and in vivo models for the study of human coronavirus pathogenesis and is finalizing the development of specific models for SARS-CoV-2. These models will be used for preclinical validation of therapeutic compounds against SARS-CoV-2, including own developments and projects in collaboration with the Spanish pharmaceutical industry for drug repositioning and immunotherapy strategies.
Principal Investigators: Luis Enjuanes, Isabel Sola, Sonia Zúñiga, Leonor Kremer
COVID-19 Project. Centro Nacional de Biotecnología (CNB)-CSIC
